Manchester Asthma and Allergy Study - primary prevention of asthma and allergy by allergen avoidance in high risk infants

Manchester Asthma and Allergy Study - primary prevention of asthma and allergy by allergen avoidance in high risk infants: a randomised controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN63558189

Enrollment

300

Registered

2005-10-19

Start date

1995-09-01

Completion date

Unknown

Last updated

2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma Respiratory Asthma

Interventions

House dust mite allergen avoidance versus no intervention.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: High-risk children (both parents atopic) of either sex born at Wythenshawe Hospital Manchester and Stepping Hill Hospital Stockport between January 1996 and April 1998

Exclusion criteria

Exclusion criteria: Premature birth less than 32 weeks gestation

Design outcomes

Primary

Measure	Time frame
1. Asthma at age 5, 8, 11, and 14 years 2. Sensitisation at age 1, 3, 5, 8, 11 and 14 years	—

Secondary

Measure	Time frame
Wheeze and eczema at age 1, 3, 5, 8, 11 and 14 years	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026